Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y014059 | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y014059 | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y014059 | — |
No adverse event; patient was accidently given 3 doses of GARDASIL-9 over a two week period.; This spontaneous report was received from a nurse referring to a 41-year-old female patient. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On 31-MAR-2025, 07-APR-2025 and 14-APR-2025, over a two-week period, the patient received respectively the first, second and third dose of human papillomavirus (GARDASIL 9) injection, as a dose of 0.5 ml for prophylaxis (route of administration, anatomical location was not reported, lot number Y014059 with an expiration date on 20-NOV-2026). (Inappropriate schedule of product administration). There was no adverse effect reported.